Skip to main content

Table 4 Ingenuity Pathway Analysis of differentially methylated genes

From: A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

 

p value

Overlap n (%)

Arm A top canonical pathways

 Neuropathic pain signaling in doral horn neurons

7.5e−12

35/100 (35.0%)

 Glutamate receptor signaling

2.45e−11

25/57 (43.9%)

 Amyotrophic lateral sclerosis signaling

2.05e−09

31/98 (31.6%)

 Synaptic long-term potentiation

1.00e−06

30/119 (25.2%

 Hepatic fibrosis/hepatic stellate cell activation

1.01e−06

40/183 (21.9%)

Arm B top canonical pathways

 Transcriptional regulatory network in embryonic stem cells

2.68e−04

4/40 (10.0%)

 Thrombin signaling

7.94e−04

7/191 (3.7%)

 GPCR-mediated integration of enteroendocrine signaling Exemplified by an L Cell

2.36e−03

4/71 (5.6%)

 Signaling by Rho Family GTPases

2.54e−03

7/234 (3.0%)

 CXCR4 signaling

7.03e−03

5/152 (3.3%)

  1. Differentially methylated genes for Arm A (decitabine + chemotherapy; n = 2518) and Arm B (chemotherapy alone; n = 539) were entered into the core pathway analysis option. Top 5 canonical pathways are shown along with a significant p value and the number of genes in each list belonging to the pathway